Core Scientific (CORZ) to Release Earnings on Wednesday

Core Scientific (NASDAQ:CORZ) will likely be posting its Q1 2026 results after the market closes on Wednesday, May 6th. Analysts expect the company to announce earnings of ($0.02) per share and revenue of $119.1270 million for the quarter. Parties may visit the the company’s upcoming Q1 2026 earning results page for the latest details on the call scheduled for Wednesday, May 6, 2026 at 4:30 PM ET.

Core Scientific (NASDAQ:CORZ) last issued its quarterly earnings results on Monday, March 2nd. The company reported $0.42 EPS for the quarter, beating the consensus estimate of ($0.27) by $0.69. The business had revenue of $79.76 million during the quarter, compared to analysts’ expectations of $118.45 million. During the same period in the prior year, the business earned ($0.69) EPS. The business’s quarterly revenue was down 16.0% on a year-over-year basis. On average, analysts expect Core Scientific to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Core Scientific Stock Up 3.7%

Shares of CORZ stock opened at $21.10 on Tuesday. Core Scientific has a 52 week low of $8.39 and a 52 week high of $23.63. The stock has a market capitalization of $6.66 billion, a PE ratio of 18.03 and a beta of 5.45. The firm has a 50 day moving average of $17.41 and a two-hundred day moving average of $17.42.

Insider Activity

In other news, insider Todd M. Duchene sold 10,000 shares of the company’s stock in a transaction on Monday, April 27th. The shares were sold at an average price of $20.94, for a total value of $209,400.00. Following the completion of the transaction, the insider owned 1,990,348 shares in the company, valued at approximately $41,677,887.12. This represents a 0.50% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. In the last ninety days, insiders have sold 40,000 shares of company stock valued at $724,800. Corporate insiders own 1.70% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Xponance LLC boosted its holdings in shares of Core Scientific by 2.5% in the 4th quarter. Xponance LLC now owns 22,896 shares of the company’s stock valued at $333,000 after buying an additional 562 shares in the last quarter. Orion Porfolio Solutions LLC boosted its holdings in shares of Core Scientific by 5.2% in the 3rd quarter. Orion Porfolio Solutions LLC now owns 15,539 shares of the company’s stock valued at $279,000 after buying an additional 766 shares in the last quarter. Bank of Montreal Can boosted its holdings in shares of Core Scientific by 4.2% in the 4th quarter. Bank of Montreal Can now owns 21,592 shares of the company’s stock valued at $314,000 after buying an additional 869 shares in the last quarter. Allworth Financial LP boosted its holdings in shares of Core Scientific by 206.5% in the 3rd quarter. Allworth Financial LP now owns 1,410 shares of the company’s stock valued at $25,000 after buying an additional 950 shares in the last quarter. Finally, Pathstone Holdings LLC boosted its holdings in shares of Core Scientific by 1.3% in the 3rd quarter. Pathstone Holdings LLC now owns 76,094 shares of the company’s stock valued at $1,365,000 after buying an additional 967 shares in the last quarter.

Wall Street Analyst Weigh In

CORZ has been the subject of several recent research reports. Zacks Research raised shares of Core Scientific from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 13th. BTIG Research raised shares of Core Scientific from a “neutral” rating to a “buy” rating and set a $23.00 price target for the company in a research report on Tuesday, January 6th. HC Wainwright reissued a “buy” rating and issued a $25.00 price target on shares of Core Scientific in a research report on Tuesday, March 3rd. Needham & Company LLC raised shares of Core Scientific from a “hold” rating to a “buy” rating and set a $23.00 price target for the company in a research report on Tuesday, March 3rd. Finally, Wall Street Zen raised shares of Core Scientific to a “sell” rating in a research report on Saturday, March 14th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $25.07.

About Core Scientific

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.